Post by
Hideaway on Dec 11, 2024 3:31pm
PR
Further dilution with another 20M shares added to the mix.
$1M dollars will pay the Board but will not advance the DPX trials.They are in desperate need of need for a partner which I see as improbable.It might of been Passin's hope when he bought IMV but It is doubtful that that big pharma could persuaded to participate.
Amyone else have a more positive view.